Biomanufacturing Consultations – Consultations Open Until March 12
Earlier this year, the Government of Canada invited submissions on the topic of considering the creation of new biomanufacturing capacity for Canadians. Innovation, Science and Economic Development Canada (ISED), in partnership with Health Canada, and the Public Health Agency of Canada (PHAC), requested input and feedback from stakeholders to inform its goal of rebuilding a robust domestic biomanufacturing sector, including the expansion of domestic manufacturing capacity and related enhancements to the life sciences ecosystem. The mandate proposed from ISED includes: Ensuring Canada retains and develops its biological intellectual property from research discoveries through commercialization. In its 2020 Fall Economic Statement, the Government of Canada committed to explore ways it can support pandemic preparedness going forward.
National Strategy for Rare Diseases – Consultations Open Until March 26
On January 27, 2021, the Government announced a consultation titled the National Strategy for High-Cost Drugs for Rare Diseases Online Engagement. Health Canada is inviting Canadians to read their discussion paper and provide feedback around key considerations and questions for developing a national strategy for high-cost drugs for rare diseases. In its 2020 Fall Economic Statement, the Government of Canada reaffirmed Budget 2019’s commitment to funding $1 billion over two years starting 2022-23 with up to $500 million per year thereafter towards Canada’s rare drug strategy.
Town Hall Dates:
Canadians still have the opportunity to register to attend online public town halls as part of the consultation process:
- Public Town Hall #4 – Friday March 12, 2021 (Bilingual) – 10:00 – 11:30am ET (Register)
- Public Town Hall #5 – Tuesday March 23, 2021 (Bilingual) – 3:00 – 4:30pm ET (Register)
With the close of these Government of Canada consultations on March 12 and March 26, PDCI is inviting all stakeholders to share their input for public awareness and information. PDCI strives to support timely transparency around public policy consultations and invites organizations and individuals to share their submissions here so ideas may be shared publicly. PDCI has begun collecting responses and will soon be posting stakeholder comments on the PDCI response sharing page. A reminder that the PDCI sharing page for the PMPRB Amended Final Guidelines Consultations is still open to publishing stakeholder consultations.
Please e-mail Julia Shen, Associate, Policy and Health Economic Research, at Julia.email@example.com with a PDF version of your response including consent for PDCI to publish the response on its website.
Thank you to all stakeholders who shared their responses.
Note: ISED will be publishing all submissions it receives as part of the biomanufacturing consultation, however timing for this is not yet clear. Once ISED publishes the comprehensive set of submissions, PDCI’s sharing page will direct visitors to the comprehensive set of submissions on the ISED website.